| Fund ID | 805-6922020878 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 6% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Alerce Medical Technology Partners, L.P. | Private Equity | $79.2M |
| Alerce Medical Technology Partners, L.P., Class 2023-2 | Private Equity | $37.1M |
| Alerce Medical Technology Partners, L.P., Class 2024-1 | Private Equity | $37M |
Smtp Co-Invest II (awc), L.P. reports $649,883 in gross assets, among the top 96% of private funds by size.
Smtp Co-Invest II (awc), L.P. is managed by Alerce Investment Management, L.P.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.